Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia

The addition of methotrexate to treatment protocols in children with acute lymphoblastic leukemia has been found beneficial in preventing central nervous system relapse. However, MTX itself may be associated with neurologic morbidities, the most significant of which is leukoencephalopathy. The prese...

Full description

Saved in:
Bibliographic Details
Published in:The Israel Medical Association journal 2002-11, Vol.4 (11), p.1050
Main Authors: Shuper, Avinoam, Stark, Batia, Kornreich, Liora, Cohen, Ian J, Avrahami, Gali, Yaniv, Isaac
Format: Article
Language:English
Subjects:
Antimetabolites, Antineoplastic - adverse effects
Antimetabolites, Antineoplastic - metabolism
Antimetabolites, Antineoplastic - therapeutic use
Child
Drug Interactions
Humans
Leucovorin - therapeutic use
Methotrexate - adverse effects
Methotrexate - metabolism
Methotrexate - therapeutic use
Neurotoxicity Syndromes - etiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Tetrahydrofolate Dehydrogenase - drug effects
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The addition of methotrexate to treatment protocols in children with acute lymphoblastic leukemia has been found beneficial in preventing central nervous system relapse. However, MTX itself may be associated with neurologic morbidities, the most significant of which is leukoencephalopathy. The present study describes the clinical spectrum of leukoencephalopathy, which ranges from a subclinical disease manifested only radiologically to a progressive, devastating encephalopathy. The interaction of MTX with other components of the treatment protocol is discussed, as is the effect of leucovorin. A summary is presented of the metabolic pathways that may be involved in the development of MTX toxicity. Researchers are still seeking a biochemical marker to aid in the determination of the amount of MTX that may be safely administered.
ISSN:1565-1088